Evidence map›Paper›PMID 39876094›Full record

ArticleProtein science : a publication of the Protein Society2025

Accelerated amyloid fibril formation at the interface of liquid-liquid phase-separated droplets by depletion interactions.

Keiichi Yamaguchi, Joji Mima, Kichitaro Nakajima, Hiroki Sakuta, Kenichi Yoshikawa, Yuji Goto

Abstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Keiichi YamaguchiGraduate School of Engineering, Osaka University, Osaka, Japan.ORCID 0000-0003-3408-1980
Joji MimaGraduate School of Engineering, Osaka University, Osaka, Japan.
Kichitaro NakajimaGraduate School of Engineering, Osaka University, Osaka, Japan.
Hiroki SakutaFaculty of Life and Medical Sciences, Doshisha University, Kyoto, Japan.
Kenichi YoshikawaFaculty of Life and Medical Sciences, Doshisha University, Kyoto, Japan.
Yuji GotoGraduate School of Engineering, Osaka University, Osaka, Japan.ORCID 0000-0003-1221-1270

Funding

Japan Society for the Promotion of ScienceJKA and its promotion funds from AUTORACE
6 · The paper itself

Abstract

Amyloid fibril formation of α-synuclein (αSN) is a hallmark of synucleinopathies. Although the previous studies have provided numerous insights into the molecular basis of αSN amyloid formation, it remains unclear how αSN self-assembles into amyloid fibrils in vivo. Here, we show that αSN amyloid formation is accelerated in the presence of two macromolecular crowders, polyethylene glycol (PEG) (MW: ~10,000) and dextran (DEX) (MW: ~500,000), with a maximum at approximately 7% (w/v) PEG and 7% (w/v) DEX. Under these conditions, the two crowders induce a two-phase separation of upper PEG and lower DEX phases with a small number of liquid droplets of DEX and PEG in PEG and DEX phases, respectively. Fluorescence microscope images revealed that the interfaces of DEX droplets in the upper PEG phase are the major sites of amyloid formation. We consider that the depletion interactions working in micro phase-segregated state with DEX and PEG systems causes αSN condensation at the interface between solute PEG and DEX droplets, resulting in accelerated amyloid formation. Ultrasonication further accelerated the amyloid formation in both DEX and PEG phases, confirming the droplet-dependent amyloid formation. Similar PEG/DEX-dependent accelerated amyloid formation was observed for amyloid β peptide. In contrast, amyloid formation of β

Indexed as

alpha-SynucleinAmyloidDextransPolyethylene GlycolsHumansalpha-SynucleinAmyloidDextransPolyethylene Glycolsliquid dropletmacromolecular crowdingsupersaturationα‐Synucleinβ2‐microglobulin

Identifiers

PMID39876094
PMCPMC11774873

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.